Arvinas
ARVN
125 hedge funds and large institutions have $1.3B invested in Arvinas in 2020 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 52 increasing their positions, 31 reducing their positions, and 26 closing their positions.
474% more call options, than puts
Call options by funds: $8.3M | Put options by funds: $1.45M
68% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 31
5.33% more ownership
Funds ownership: 77.4% → 82.73% (+5.3%)
5% more capital invested
Capital invested by funds: $1.24B → $1.3B (+$63M)
8% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 26
1% more funds holding
Funds holding: 124 → 125 (+1)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$90.9M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$73.7M |
| 3 |
Holocene Advisors
New York
|
+$16.1M |
| 4 |
UBS AM
Chicago,
Illinois
|
+$14.1M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$10.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$42.3M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$20.2M |
| 3 |
5VM
5AM Venture Management
San Francisco,
California
|
-$17.7M |
| 4 |
PA
Perceptive Advisors
New York
|
-$16.4M |
| 5 |
RI
RTW Investments
New York
|
-$15.2M |
ARVN Hedge Fund Activity: Q1 2020 in Review
125 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Arvinas (ARVN) for Q1 2020, worth a combined $1.3B — up 5.1% from $1.24B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new ARVN positions and 26 closed out — a net gain of 2 holders — while 52 added to existing stakes and 31 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $90.9M. The largest seller was OrbiMed, cutting an estimated $42.3M.
- 125 institutional investors held Arvinas (ARVN) as of Q1 2020, up from 124 in Q4 2019.
- Funds reported $1.3B of Arvinas stock for Q1 2020, up 5.1% quarter-over-quarter.
- 28 funds opened new Arvinas positions in Q1 2020 and 26 closed out, a net change of +2 holders.
- The largest Arvinas buyer in Q1 2020 was Fidelity Investments, an estimated $90.9M added.
- The largest Arvinas seller in Q1 2020 was OrbiMed, an estimated $42.3M sold.
Based on aggregated 13F filings for Q1 2020.